<DOC>
	<DOC>NCT01248429</DOC>
	<brief_summary>This study describes the elevation of CPK in patient treated for solid tumors by TKI</brief_summary>
	<brief_title>Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases</brief_title>
	<detailed_description />
	<criteria>Patients with solid tumor treated by inhibitor of tyrosin kinase for at least 1 week Patient examined AND with a routine blood test planned Patient informed of procedure for the study who was not opposed to it Patient treated for malignant hemopathy Patient no treated by inhibitor of thyrosine kinase or for less than 1 week Patients with no routine blood laboratory tests planned</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>thyrosine kinase inhibitor</keyword>
	<keyword>phosphokinase creatinin</keyword>
	<keyword>myalgia</keyword>
</DOC>